Table 3.
Univariate Analysis and Multivariable logistic regression model considering death as outcome. Statistically significancy comparisons are highlighted in bold.
Univariate |
Multivariable |
|||
---|---|---|---|---|
Characteristics | OR (95% CI) | p-value | OR (95% CI) | p-value |
Gender | 1.31 (0.83–2.06) | 0.24 | ||
Age | 1.08 (1.06–1.10) | <0.001 | 1.09 (1.05–1.13) | <0.001 |
BMI | 1.00 (0.96–1.04) | 0.84 | ||
Comorbidities | ||||
Number of comorbidities | 1.61 (1.37–1.88) | <0.001 | 1.50 (0.98–2.29) | 0.06 |
Chronic liver disease, n (%) | 1.44 (0.89–2.34) | 0.14 | ||
CV disease, n (%) | 3.76 (2.40–5.89) | <0.001 | 1.26 (0.55–2.88) | 0.58 |
Diabetes, n (%) | 1.96 (1.21–3.18) | 0.006 | 0.75 (0.31–1.82) | 0.53 |
Hypertension, n (%) | 1.58 (1.03–2.44) | 0.04 | 0.53 (0.24–1.18) | 0.12 |
Pulmonary disease, n (%) | 1.46 (0.83–2.55) | 0.19 | ||
Malignancy, n (%) | 3.59 (1.98–6.50) | <0.001 | 2.44 (0.90–6.61) | 0.08 |
Other comorbidities, n (%) | 2.00 (1.26–3.18) | 0.003 | ||
Laboratory test at admission | ||||
GGT at admission | 1.00 (0.99–1.00) | 0.89 | ||
ALT at admission | 0.99 (0.98–1.00) | 0.14 | ||
Peak GGT | 1.00 (0.99–1.00) | 0.17 | ||
Peak ALP | 1.005 (1.001–1.008) | 0.001 | 1.01 (1.00–1.01) | 0.01 |
Peak ALT | 0.99 (0.98–0.99) | 0.004 | 0.99 (0.99–1.00) | 0.07 |
Peak AST | 0.99 (0.99–1.00) | 0.65 | ||
Peak GGT ≥ 5X | 1.38 (0.58–3.25) | 0.47 | ||
Peak ALT ≥ 5X | 0.52 (0.15–1.83) | 0.31 | ||
Peak AST ≥ 5X | 0.77 (0.25–2.40) | 0.65 | ||
Peak transaminases | 0.74 (0.27–2.05) | 0.56 | ||
Grade ≥ 1 | 0.60 (0.32–1.13) | 0.11 | ||
Illness gravity | ||||
Severe ARDS | 2.73 (1.36–5.49) | 0.005 | ||
Admission to ICU | 2.99 (1.82–4.92) | <0.001 | 5.22 (2.28–11.90) | < 0.001 |
OR odds ratio, BMI body mass index, CV cardiovascular, GGT gamma-glutamyl transferase, ALT alanine aminotransferase, ALP alkaline phosphatase, AST aspartate aminotransferase, ARDS acute respiratory distress syndrome, ICU intensive care unit.